Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[3/9 held] AI-based support tool for new strategy formulation "Word ATLAS" -Non-biased competitive analysis and visualization of KOL trends-


In this seminar,Introducing "Word ATLAS", a system that analyzes and visualizes medical papers and author information contained in PubMed * using FRONTEO's original natural language analysis AI engine "Concept Encoder".To do. "Word ATLAS" improves the efficiency of research and development in the fields of medicine and drug discovery as a support tool for selecting collaborators and collaborative facilities in basic research, clinical research, and clinical trials, and formulating medical marketing strategies including competitive analysis. We support the promotion of acceleration and sharing of knowledge.

We often ask about the following dilemmas and needs.
"Word ATLAS" is a strategy development support tool created based on these needs.
(XNUMX) KOL analysis relies on external surveys and has become a snapshot type (spot) analysis in a predetermined area.
(XNUMX) I want to comprehensively, objectively and timely grasp the quality and quantity of papers related to products.
③ I want to know not only the product but also the area and the momentum of KOL.
(XNUMX) I would like to comprehensively and objectively look at the KOL-related values ​​on a performance-based basis (thesis-based).

 


【Webinar Summary】

◆ Theme: "Word ATLAS", a support tool for new strategy formulation utilizing AI-Visualization of competitive analysis and KOL trends without bias-
◆ Date: September 2022, 3 (Wednesday) 9: 17-00: 17
◆ Agenda
(XNUMX) Market trends related to medical DX
② FRONTEO's AI solutions in general
③Introduction of Word ATLAS
④ QA
◆ Recommended for people like this!
・ Those who work for a pharmaceutical company
・ Persons in charge of R & D, Business Development Department, Marketing Department, etc.
・ Those who want to realize new strategy formulation by utilizing AI
◆ Participation conditions
Please refrain from applying for those who use free addresses, those who are in the same industry as our company, or those whose affiliation is unknown.When accessing ZOOM on the day of the event, please enter the name and email address you provided when you applied for the ZOOM participation input field.
 
 

 
Speakers/panelist:
 
FRONTEO Inc. Life Science AI Business Headquarters Medical DX Team Manager
Tomoya Ohsumi
 
After joining IQVIA in 2006, after working in a sales position (MR), he became a project manager, group manager, and new business development manager.He is in charge of marketing, training, consulting and medical related projects with a focus on oncology.He is involved in launching new businesses and organizational reforms such as oncology MRs, MSLs, and clinical educators. From 2019, he will launch a new service for patients as the person in charge of new business development of the patient support program. He received a Master of Business Administration (MBA) from Waseda University Business School in 2020.While in school, he conducted quantitative research on the clinical development of prescription drugs and wrote a master's thesis.
Joined FRONTEO in 2021 and became the head of the medical DX team of the Life Science AI Business Headquarters. Challenge to solve medical problems by utilizing AI.
 
 
FRONTEO Inc. Life Science AI Business Headquarters Medical DX Team
Yukari Oda
 
After serving as a manager in the food industry, such as store management, he entered the healthcare industry.He is involved in the sales of drugs and infusions at multiple pharmaceutical companies.He has experienced a wide range of disease areas such as cardiovascular, respiratory, skin and metabolic endocrine areas. He joined FRONTEO and is currently proposing AI solutions mainly to pharmaceutical companies. 
 
Share this article